You expect Nader to put the worst spin on things?
Post# of 148188
Anyone that's been here for any length of time knows the massive potential of leronlimab. It's taking longer than expected, so be it. The end results will be worth the long ride.
I have to say there are quite a few whiners who own or owned this stock. This isn't Tesla this is a biotech stock if you don't know the risk/reward/time of biotech then you shouldn't dabble. When I switched over to biotech's in 2018 I had a decent idea of all three. I still got walloped with VSTM and was down a little on two others but I didn't cry about it I just found a better stock which was Cytodyn.